Treatment of adult-onset Still’s disease: a review

References

• BywatersEGStill’s disease in the adultAnn Rheum Dis19713021211335315135
   PubMed Web of Science ®Google Scholar
• StillGFOn a form of chronic joint disease in childrenMed Chir Trans1897804760.9
   PubMedGoogle Scholar
• EfthimiouPPaikPKBieloryLDiagnosis and management of adult onset Still’s diseaseAnn Rheum Dis200665556457216219707
   PubMed Web of Science ®Google Scholar
• TanakaSMatsumotoYOhnishiHComparison of clinical features of childhood and adult onset Still’s diseaseRyūmachi Rheum1991315511518 Japanese
   PubMedGoogle Scholar
• UppalSSPandeIRKumarAAdult onset Still’s disease in northern India: comparison with juvenile onset Still’s diseaseBr J Rheumatol19953454294347788171
   PubMedGoogle Scholar
• LuthiFZuffereyPHoferMFSoAK“Adolescent-onset Still’s disease”: characteristics and outcome in comparison with adult-onset Still’s diseaseClin Exp Rheumatol200220342743012102485
   PubMed Web of Science ®Google Scholar
• YamaguchiMOhtaATsunematsuTPreliminary criteria for classification of adult Still’s diseaseJ Rheumatol19921934244301578458
   PubMed Web of Science ®Google Scholar
• FautrelBZingEGolmardJ-LProposal for a new set of classification criteria for adult-onset Still diseaseMedicine200281319420011997716
   PubMed Web of Science ®Google Scholar
• MahroumNMahagnaHAmitalHDiagnosis and classification of adult Still’s diseaseJ Autoimmun201448493437
   Web of Science ®Google Scholar
• Gerfaud-ValentinMJamillouxYIwazJSèvePAdult-onset Still’s diseaseAutoimmun Rev201413770872224657513
   PubMed Web of Science ®Google Scholar
• McGonagleDMcDermottMFA proposed classification of the immunological diseasesPLoS Med200638e29716942393
   PubMed Web of Science ®Google Scholar
• KastnerDLAksentijevichIGoldbach-ManskyRAutoinflammatory disease reloaded: a clinical perspectiveCell2010140678479020303869
   PubMed Web of Science ®Google Scholar
• MariaATLe QuellecAJorgensenCTouitouIRivièreSGuilpainPAdult onset Still’s disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressionsAutoimmun Rev8272014 Epub ahead of print
   PubMed Web of Science ®Google Scholar
• CannaSWEditorial. Interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult Still’s diseaseArthritis Rheumatol20146651072107624470448
   PubMed Web of Science ®Google Scholar
• ShimizuMNakagishiYYachieADistinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profilesCytokine201361234534823276493
   PubMed Web of Science ®Google Scholar
• Gerfaud-ValentinMMaucort-BoulchDHotAAdult-onset Still disease: manifestations, treatments, outcome, and prognostic factors in 57 patientsMedicine (Baltimore)2014932919924646465
   PubMed Web of Science ®Google Scholar
• FranchiniSDagnaLSalvoFAielloPBaldisseraESabbadiniMGEfficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s diseaseArthritis Rheum20106282530253520506370
   PubMed Web of Science ®Google Scholar
• NigrovicPAReview: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?Arthritis Rheumatol20146661405141324623686
   PubMed Web of Science ®Google Scholar
• NigrovicPAMannionMPrinceFHAnakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter seriesArthritis Rheum201163254555521280009
   PubMed Web of Science ®Google Scholar
• VastertSJde JagerWNoordmanBJEffectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort studyArthritis Rheumatol20146641034104324757154
   PubMed Web of Science ®Google Scholar
• MoulisGSaillerLAstudilloLPugnetGArletPMay anakinra be used earlier in adult onset Still disease?Clin Rheumatol201029101199120020428907
   PubMed Web of Science ®Google Scholar
• DeWittEMKimuraYBeukelmanTConsensus treatment plans for new-onset systemic juvenile idiopathic arthritisArthritis Care Res201264710011010
   PubMed Web of Science ®Google Scholar
• PaySTürkçaparNKalyoncuMA multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritisClin Rheumatol200625563964416365690
   PubMed Web of Science ®Google Scholar
• NagashimaTIwamotoMMatsumotoKMinotaSInterleukin-18 in adult-onset Still’s disease: treatment target or disease activity indicator?Intern Med201251444922333388
   PubMed Web of Science ®Google Scholar
• KimH-ASungJ-MSuhC-HTherapeutic responses and prognosis in adult-onset Still’s diseaseRheumatol Int20123251291129821274538
   PubMed Web of Science ®Google Scholar
• PouchotJSampalisJSBeaudetFAdult Still’s disease: manifestations, disease course, and outcome in 62 patientsMedicine (Baltimore)19917021181362005777
   PubMed Web of Science ®Google Scholar
• MitamuraMTadaYKoaradaSCyclosporin A treatment for Japanese patients with severe adult-onset Still’s diseaseMod Rheumatol2009191576318839270
   PubMed Web of Science ®Google Scholar
• NakamuraHOdaniTShimizuYTakedaTKikuchiHUsefulness of tacrolimus for refractory adult-onset Still’s disease: report of six casesMod Rheumatol20141815
   Google Scholar
• FautrelBBorgetCRozenbergSCorticosteroid sparing effect of low dose methotrexate treatment in adult Still’s diseaseJ Rheumatol19992623733789972972
   PubMed Web of Science ®Google Scholar
• VignesSWechslerBAmouraZIntravenous immunoglobulin in adult Still’s disease refractory to non-steroidal anti-inflammatory drugsClin Exp Rheumatol19981632952989631752
   PubMed Web of Science ®Google Scholar
• PermalSWechslerBCabaneJPerrotSBlumLImbertJCTreatment of Still’s disease in adults with intravenous immunoglobulinsRev Med Interne1995164250254 French7746963
   PubMedGoogle Scholar
• EmmeneggerUFreyUReimersAHyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromesAm J Hematol200168141011559930
   PubMed Web of Science ®Google Scholar
• LiozonELyKAubardYVidalEIntravenous immunoglobulins for adult Still’s disease and pregnancyRheumatology199938101024102510534562
   PubMed Web of Science ®Google Scholar
• Gerfaud-ValentinMHotAHuissoudCDurieuIBroussolleCSevePAdult-onset Still’s disease and pregnancy: about ten cases and review of the literatureRheumatol Int201434686787123624554
   PubMed Web of Science ®Google Scholar
• LequerréTQuartierPRoselliniDInterleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in FranceAnn Rheum Dis200867330230817947302
   PubMed Web of Science ®Google Scholar
• BenucciMLiGFDel RossoAManfrediMAdalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still’s disease: the first case reportClin Exp Rheumatol200523573316173267
   PubMed Web of Science ®Google Scholar
• FelsonDTAndersonJJBoersMAmerican College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritisArthritis Rheum19953867277357779114
   PubMed Web of Science ®Google Scholar
• HusniMEMaierALMeasePJEtanercept in the treatment of adult patients with Still’s diseaseArthritis Rheum20024651171117612115220
   PubMedGoogle Scholar
• CavagnaLCaporaliREpisOBobbio-PallaviciniFMontecuccoCInfliximab in the treatment of adult Still’s disease refractory to conventional therapyClin Exp Rheumatol200119332933211407090
   PubMed Web of Science ®Google Scholar
• KraetschHGAntoniCKaldenJRMangerBSuccessful treatment of a small cohort of patients with adult onset of Still’s disease with infliximab: first experiencesAnn Rheum Dis200160Suppl 3iii55iii5711890655
   PubMed Web of Science ®Google Scholar
• KokkinosAIliopoulosAGrekaPEfthymiouAKatsilambrosNSfikakisPPSuccessful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patientsClin Rheumatol2004231454914749983
   PubMed Web of Science ®Google Scholar
• FautrelBSibiliaJMarietteXCombeBClub Rhumatismes et InflammationTumour necrosis factor alpha blocking agents in refractory adult Still’s disease: an observational study of 20 casesAnn Rheum Dis200564226226615184196
   PubMed Web of Science ®Google Scholar
• AikawaNERibeiroACSaadCGIs anti-TNF switching in refractory Still’s disease safe and effective?Clin Rheumatol20113081129113421465126
   PubMed Web of Science ®Google Scholar
• KanekoKKaburakiMMuraokaSExacerbation of adult-onset Still’s disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administrationInt J Rheum Dis2010134e67e6921199457
   PubMed Web of Science ®Google Scholar
• AgarwalSMoodleyJAjani GoelGTheilKSMahmoodSSLangRSA rare trigger for macrophage activation syndromeRheumatol Int201131340540719834709
   PubMed Web of Science ®Google Scholar
• Vasques GodinhoFMParreira SantosMJCanas da SilvaJRefractory adult onset Still’s disease successfully treated with anakinraAnn Rheum Dis200564464764815374853
   PubMed Web of Science ®Google Scholar
• FitzgeraldAALeclercqSAYanAHomikJEDinarelloCARapid responses to anakinra in patients with refractory adult-onset Still’s diseaseArthritis Rheum20055261794180315934079
   PubMed Web of Science ®Google Scholar
• KallioliasGDGeorgiouPEAntonopoulosIAAndonopoulosAPLiossisSNAnakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trialAnn Rheum Dis200766684284317513574
   PubMed Web of Science ®Google Scholar
• KötterIWackerAKochSAnakinra in patients with treatment-resistant adult-onset Still’s disease: four case reports with serial cytokine measurements and a review of the literatureSemin Arthritis Rheum200737318919717583775
   PubMed Web of Science ®Google Scholar
• LaskariKTzioufasAGMoutsopoulosHMEfficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still’s disease: a case-series studyArthritis Res Ther2011133R9121682863
   PubMed Web of Science ®Google Scholar
• RudinskayaATrockDHSuccessful treatment of a patient with refractory adult-onset Still disease with anakinraJ Clin Rheumatol20039533033217041487
   PubMed Web of Science ®Google Scholar
• NordströmDKnightALuukkainenRBeneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still’s disease. An open, randomized, multicenter studyJ Rheumatol201239102008201122859346
   PubMed Web of Science ®Google Scholar
• Lo GulloACarusoAPipitoneNMacchioniPPazzolaGSalvaraniCCanakinumab in a case of adult onset Still’s disease: efficacy only on systemic manifestationsJoint Bone Spine201481437637724462130
   PubMed Web of Science ®Google Scholar
• KontziasAEfthimiouPThe use of canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still’s diseaseSemin Arthritis Rheum201242220120522512815
   PubMed Web of Science ®Google Scholar
• RupertoNQuartierPWulffraatNA phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic featuresArthritis Rheum201264255756721953497
   PubMed Web of Science ®Google Scholar
• RupertoNBrunnerHIQuartierPTwo randomized trials of canakinumab in systemic juvenile idiopathic arthritisN Engl J Med2012367252396240623252526
   PubMed Web of Science ®Google Scholar
• SwartJFBarugDMöhlmannMWulffraatNMThe efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritisExpert Opin Biol Ther201010121743175220979564
   PubMed Web of Science ®Google Scholar
• QuartierPAllantazFCimazRA multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Ann Rheum Dis201170574775421173013
   PubMed Web of Science ®Google Scholar
• PuéchalXDeBandtMBerthelotJ-MTocilizumab in refractory adult Still’s diseaseArthritis Care Res2011631155159
   PubMed Web of Science ®Google Scholar
• CiprianiPRuscittiPCarubbiFTocilizumab for the treatment of adult-onset Still’s disease: results from a case seriesClin Rheumatol2014331495524005839
   PubMed Web of Science ®Google Scholar
• ElkayamOJiriesNDranitzkiZTocilizumab in adult-onset Still’s disease: the Israeli experienceJ Rheumatol201441224424724429168
   PubMed Web of Science ®Google Scholar
• Ortiz-SanjuánFBlancoRCalvo-RioVEfficacy of tocilizumab in conventional treatment-refractory adult-onset Still’s disease: multicenter retrospective open-label study of thirty-four patientsArthritis Rheumatol20146661659166524515813
   PubMed Web of Science ®Google Scholar
• De BenedettiFBrunnerHIRupertoNRandomized trial of tocilizumab in systemic juvenile idiopathic arthritisN Engl J Med2012367252385239523252525
   PubMed Web of Science ®Google Scholar
• YokotaSImagawaTMoriMEfficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trialLancet20083719617998100618358927
   PubMed Web of Science ®Google Scholar
• CushJJMedsgerTAJrChristyWCHerbertDCCoopersteinLAAdult-onset Still’s disease. Clinical course and outcomeArthritis Rheum19873021861943827959
   PubMed Web of Science ®Google Scholar
• WoutersJMvan de PutteLBAdult-onset Still’s disease; clinical and laboratory features, treatment and progress of 45 casesQ J Med198661235105510653659248
   PubMedGoogle Scholar
• KongX-DXuDZhangWZhaoYZengXZhangFClinical features and prognosis in adult-onset Still’s disease: a study of 104 casesClin Rheumatol20102991015101920549276
   PubMed Web of Science ®Google Scholar
• KimYJKooBSKimY-GLeeC-KYooBClinical features and prognosis in 82 patients with adult-onset Still’s diseaseClin Exp Rheumatol2014321283324050706
   PubMed Web of Science ®Google Scholar
• KoizumiRTsukadaYIdeuraHUekiKMaezawaANojimaYTreatment of adult Still’s disease with dexamethasone, an alternative to prednisoloneScand J Rheumatol200029639639811132211
   PubMed Web of Science ®Google Scholar
• HotATohM-LCoppéréBReactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patientsMedicine (Baltimore)2010891374620075703
   PubMed Web of Science ®Google Scholar
• PavySConstantinAPhamTMethotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinionJoint Bone Spine200673438839516626993
   PubMed Web of Science ®Google Scholar
• ChenD-YLanJ-LLinF-JHsiehT-YProinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still’s diseaseJ Rheumatol200431112189219815517632
   PubMed Web of Science ®Google Scholar
• FujiiTNojimaTYasuokaHCytokine and immunogenetic profiles in Japanese patients with adult Still’s disease. Association with chronic articular diseaseRheumatology200140121398140411752512
   PubMed Web of Science ®Google Scholar
• IchidaHKawaguchiYSugiuraTClinical manifestations of adult-onset Still’s disease presenting with erosive arthritis: association with low levels of ferritin and IL-18Arthritis Care Res (Hoboken)1072013 Epub ahead of print
   Web of Science ®Google Scholar
• ShimizuMYokoyamaTYamadaKDistinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesisRheumatology20104991645165320472718
   PubMed Web of Science ®Google Scholar
• GattornoMPicciniALasiglièDThe pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritisArthritis Rheum20085851505151518438814
   PubMed Web of Science ®Google Scholar
• PouchotJArletJ-BBiological treatment in adult-onset Still’s diseaseBest Pract Res Clin Rheumatol201226447748723040362
   PubMed Web of Science ®Google Scholar
• LinY-TWangC-TGershwinMEChiangB-LThe pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritisAutoimmun Rev201110848248921320644
   PubMed Web of Science ®Google Scholar
• MellinsEDMacaubasCGromAAPathogenesis of systemic juvenile idiopathic arthritis: some answers, more questionsNat Rev Rheumatol20117741642621647204
   PubMed Web of Science ®Google Scholar
• ArletJ-BLeTHMarinhoAReactive haemophagocytic syndrome in adult-onset Still’s disease: a report of six patients and a review of the literatureAnn Rheum Dis200665121596160116540551
   PubMed Web of Science ®Google Scholar
• RavelliAGromAABehrensEMCronRQMacrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatmentGenes Immun201213428929822418018
   PubMed Web of Science ®Google Scholar
• BehrensEMBeukelmanTPaesslerMCronRQOccult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritisJ Rheumatol20073451133113817343315
   PubMed Web of Science ®Google Scholar
• EfthimiouPKadavathSMehtaBLife-threatening complications of adult-onset Still’s diseaseClin Rheumatol201433330531424435354
   PubMed Web of Science ®Google Scholar
• SilvaCASilvaCHRobazziTCMacrophage activation syndrome associated with systemic juvenile idiopathic arthritisJ Pediatr (Rio J)2004806517522 Portuguese15622430
   PubMedGoogle Scholar
• RamananAVSchneiderRMacrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritisJ Rheumatol200330240140312563702
   PubMed Web of Science ®Google Scholar
• TristanoAGMacrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseasesMed Sci Monit2008143RA27RA3618301366
   PubMed Web of Science ®Google Scholar
• MizrahiMBen-ChetritERelapsing macrophage activating syndrome in a 15-year-old girl with Still’s disease: a case reportJ Med Case Rep2009313820062775
   PubMedGoogle Scholar
• PamukONPamukGEUstaUCakirNHemophagocytic syndrome in one patient with adult-onset Still’s disease. Presentation with febrile neutropeniaClin Rheumatol200726579780016550302
   PubMedGoogle Scholar
• KellyARamananAVA case of macrophage activation syndrome successfully treated with anakinraNat Clin Pract Rheumatol200841161562018825135
   PubMedGoogle Scholar
• BruckNSuttorpMKabusMHeubnerGGahrMPesslerFRapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroidsJ Clin Rheumatol2011171232721169853
   PubMed Web of Science ®Google Scholar
• RecordJLBeukelmanTCronRQCombination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case seriesJ Rheumatol201138118018121196588
   PubMed Web of Science ®Google Scholar
• SternARileyRBuckleyLWorsening of macrophage activation syndrome in a patient with adult onset Still’s disease after initiation of etanercept therapyJ Clin Rheumatol20017425225617039144
   PubMed Web of Science ®Google Scholar
• KobayashiMTakahashiYYamashitaHKanekoHMimoriABenefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndromeMod Rheumatol2011211929620737186
   PubMed Web of Science ®Google Scholar
• AellenPRaccaudOWaldburgerMChamotAMGersterJCStill’s disease in adults with disseminated intravascular coagulationSchweiz Rundsch Med Prax19918015376378 German2031109
   PubMedGoogle Scholar
• AraiYHandaTMitaniKAdult-onset Still disease presenting with disseminated intravascular coagulationRinsho Ketsueki2004454316318 Japanese15168449
   PubMedGoogle Scholar
• ParkJ-HBaeJHChoiY-SAdult-onset Still’s disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine AJ Korean Med Sci200419113714114966357
   PubMed Web of Science ®Google Scholar
• YokoyamaMSuwaAShinozawaTA case of adult onset Still’s disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulationNihon Rinsho Meneki Gakkai Kaishi1995182207214 Japanese7553055
   PubMedGoogle Scholar
• MoriTTanigawaMIwasakiECyclosporine therapy of adult onset Still’s disease with disseminated intravascular coagulationNihon Rinsho Meneki Gakkai Kaishi1993342147152 Japanese
   Google Scholar
• MatsumotoKNagashimaTTakatoriSGlucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumabClin Rheumatol200928448548719184270
   PubMed Web of Science ®Google Scholar
• Gerfaud-ValentinMSèvePIwazJMyocarditis in adult-onset Still diseaseMedicine. (Baltimore)2014931728028925398063
   PubMed Web of Science ®Google Scholar
• PerezMGRodwigFRJrChronic relapsing thrombotic thrombocytopenic purpura in adult onset Still’s diseaseSouth Med J2003961464912602713
   PubMed Web of Science ®Google Scholar
• MasuyamaAKobayashiHKobayashiYA case of adult-onset Still’s disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edemaMod Rheumatol201323237938522623015
   PubMed Web of Science ®Google Scholar
• SayarliogluMSayarliogluHOzkayaMBalakanOUcarMAThrombotic thrombocytopenic purpura-hemolytic uremic syndrome and adult onset Still’s disease: case report and review of the literatureMod Rheumatol200818440340618427722
   PubMed Web of Science ®Google Scholar
• OnundarsonPTRoweJMHealJMFrancisCWResponse to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institutionArch Intern Med199215247917961558437
   PubMedGoogle Scholar
• SumidaKUbaraYHoshinoJEtanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumabClin Rheumatol201029101191119420225049
   PubMed Web of Science ®Google Scholar
• CheemaGSQuismorioFPPulmonary involvement in adult-onset Still’s diseaseCurr Opin Pulm Med19995530530910461535
   PubMedGoogle Scholar
• SariIBirlikMBinicierOA case of adult-onset Still’s disease complicated with diffuse alveolar hemorrhageJ Korean Med Sci200924115515719270830
   PubMed Web of Science ®Google Scholar
• Le LoëtXDaragonADuvalCThomineELauretPHumbertGAdult onset Still’s disease and pregnancyJ Rheumatol1993207115811618371209
   PubMed Web of Science ®Google Scholar
• LockshinMDSammaritanoLRCorticosteroids during pregnancyScand J Rheumatol Suppl19981071361389759153
   PubMedGoogle Scholar
• Fischer-BetzRSpeckerCSchneiderMSuccessful outcome of two pregnancies in patients with adult-onset Still’s disease treated with IL-1 receptor antagonist (anakinra)Clin Exp Rheumatol20112961021102322153586
   PubMed Web of Science ®Google Scholar
• BergerCTRecherMSteinerUHauserTMA patient’s wish: anakinra in pregnancyAnn Rheum Dis200968111794179519822718
   PubMed Web of Science ®Google Scholar
• GiampietroCRideneMLequerreTAnakinra in adult-onset Still’s disease: long-term treatment in patients resistant to conventional therapyArthritis Care Res2013655822826
   Web of Science ®Google Scholar